-
1
-
-
84923207012
-
Clinical features and radiological findings in large vessel vasculitis: Are Takayasu arteritis and giant cell arteritis 2 different diseases or a single entity
-
Furuta S, Cousins C, Chaudhry A, Jayne D. Clinical features and radiological findings in large vessel vasculitis: are Takayasu arteritis and giant cell arteritis 2 different diseases or a single entity? J Rheumatol 2015;42:300-8.
-
(2015)
J Rheumatol
, vol.42
, pp. 300-308
-
-
Furuta, S.1
Cousins, C.2
Chaudhry, A.3
Jayne, D.4
-
2
-
-
84948799013
-
Update on outcome measure development for large vessel vasculitis: Report from OMERACT 12
-
Aydin SZ, Direskeneli H, Sreih A, Alibaz-Oner F, Gul A, Kamali S, et al. Update on outcome measure development for large vessel vasculitis: report from OMERACT 12. J Rheumatol 2015; 42:2465-9.
-
(2015)
J Rheumatol
, vol.42
, pp. 2465-2469
-
-
Aydin, S.Z.1
Direskeneli, H.2
Sreih, A.3
Alibaz-Oner, F.4
Gul, A.5
Kamali, S.6
-
3
-
-
85037094161
-
Assessment of disease activity in large-vessel vasculitis: Results of an international Delphi exercise
-
International Delphi on Disease Activity Assessment in Large-vessel Vasculitis
-
Aydin SZ, Direskeneli H, Merkel PA; International Delphi on Disease Activity Assessment in Large-vessel Vasculitis. Assessment of disease activity in large-vessel vasculitis: results of an international Delphi exercise. J Rheumatol 2017;44:1928-32.
-
(2017)
J Rheumatol
, vol.44
, pp. 1928-1932
-
-
Aydin, S.Z.1
Direskeneli, H.2
Merkel, P.A.3
-
4
-
-
84887352284
-
Impaired quality of life, disability and mental health in Takayasu's arteritis
-
Yilmaz N, Can M, Oner FA, Kalfa M, Emmungil H, Karadag O, et al. Impaired quality of life, disability and mental health in Takayasu's arteritis. Rheumatology 2013;52:1898-904.
-
(2013)
Rheumatology
, vol.52
, pp. 1898-1904
-
-
Yilmaz, N.1
Can, M.2
Oner, F.A.3
Kalfa, M.4
Emmungil, H.5
Karadag, O.6
-
5
-
-
44949203704
-
Quality of life in patients with Takayasu's arteritis is impaired and comparable with rheumatoid arthritis and ankylosing spondylitis patients
-
Akar S, Can G, Binicier O, Aksu K, Akinci B, Solmaz D, et al. Quality of life in patients with Takayasu's arteritis is impaired and comparable with rheumatoid arthritis and ankylosing spondylitis patients. Clin Rheumatol 2008;27:859-65.
-
(2008)
Clin Rheumatol
, vol.27
, pp. 859-865
-
-
Akar, S.1
Can, G.2
Binicier, O.3
Aksu, K.4
Akinci, B.5
Solmaz, D.6
-
6
-
-
37549025067
-
Quality of life of patients with Takayasu's arteritis
-
discussion 36-7
-
Abularrage CJ, Slidell MB, Sidawy AN, Kreishman P, Amdur RL, Arora S. Quality of life of patients with Takayasu's arteritis. J Vasc Surg 2008;47:131-6; discussion 36-7.
-
(2008)
J Vasc Surg
, vol.47
, pp. 131-136
-
-
Abularrage, C.J.1
Slidell, M.B.2
Sidawy, A.N.3
Kreishman, P.4
Amdur, R.L.5
Arora, S.6
-
7
-
-
0035666795
-
Visual function and quality of life among patients with giant cell (temporal) arteritis
-
Kupersmith MJ, Speira R, Langer R, Richmond M, Peterson M, Speira H, et al. Visual function and quality of life among patients with giant cell (temporal) arteritis. J Neuroophthalmol 2001; 21:266-73.
-
(2001)
J Neuroophthalmol
, vol.21
, pp. 266-273
-
-
Kupersmith, M.J.1
Speira, R.2
Langer, R.3
Richmond, M.4
Peterson, M.5
Speira, H.6
-
8
-
-
85050735777
-
Health-related outcomes of importance to patients with Takayasu's arteritis
-
Sreih A, Alibaz-Oner F, Easley E, Davis T, Milman N, Robson J, et al. Health-related outcomes of importance to patients with Takayasu's arteritis. Clin Exp Rheumatol 2017 Sep 18 (E-pub ahead of print).
-
Clin Exp Rheumatol 2017 Sep 18 (E-pub Ahead of Print)
-
-
Sreih, A.1
Alibaz-Oner, F.2
Easley, E.3
Davis, T.4
Milman, N.5
Robson, J.6
-
9
-
-
79959972958
-
Development of outcome measures for large-vessel vasculitis for use in clinical trials: Opportunities, challenges, and research agenda
-
Direskeneli H, Aydin SZ, Kermani TA, Matteson EL, Boers M, Herlyn K, et al. Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda. J Rheumatol 2011;38:1471-9.
-
(2011)
J Rheumatol
, vol.38
, pp. 1471-1479
-
-
Direskeneli, H.1
Aydin, S.Z.2
Kermani, T.A.3
Matteson, E.L.4
Boers, M.5
Herlyn, K.6
-
10
-
-
0028343128
-
Takayasu arteritis
-
Kerr GS, Hallahan CW, Giordano J, Leavitt RY, Fauci AS, Rottem M, et al. Takayasu arteritis. Ann Intern Med 1994;120:919-29.
-
(1994)
Ann Intern Med
, vol.120
, pp. 919-929
-
-
Kerr, G.S.1
Hallahan, C.W.2
Giordano, J.3
Leavitt, R.Y.4
Fauci, A.S.5
Rottem, M.6
-
11
-
-
0028150660
-
Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis
-
Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 1994;87:671-8.
-
(1994)
QJM
, vol.87
, pp. 671-678
-
-
Luqmani, R.A.1
Bacon, P.A.2
Moots, R.J.3
Janssen, B.A.4
Pall, A.5
Emery, P.6
-
12
-
-
77956795838
-
Assessment of disease activity and progression in Takayasu's arteritis with Disease Extent Index-Takayasu
-
Aydin SZ, Yilmaz N, Akar S, Aksu K, Kamali S, Yucel E, et al. Assessment of disease activity and progression in Takayasu's arteritis with Disease Extent Index-Takayasu. Rheumatology 2010;49:1889-93.
-
(2010)
Rheumatology
, vol.49
, pp. 1889-1893
-
-
Aydin, S.Z.1
Yilmaz, N.2
Akar, S.3
Aksu, K.4
Kamali, S.5
Yucel, E.6
-
13
-
-
84887369717
-
Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010)
-
Indian Rheumatology Vasculitis (IRAVAS) group
-
Misra R, Danda D, Rajappa SM, Ghosh A, Gupta R, Mahendranath KM, et al; Indian Rheumatology Vasculitis (IRAVAS) group. Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010). Rheumatology 2013;52:1795-801.
-
(2013)
Rheumatology
, vol.52
, pp. 1795-1801
-
-
Misra, R.1
Danda, D.2
Rajappa, S.M.3
Ghosh, A.4
Gupta, R.5
Mahendranath, K.M.6
-
14
-
-
3142685997
-
Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis
-
Hoffman GS, Merkel PA, Brasington RD, Lenschow DJ, Liang P. Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis Rheum 2004;50:2296-304.
-
(2004)
Arthritis Rheum
, vol.50
, pp. 2296-2304
-
-
Hoffman, G.S.1
Merkel, P.A.2
Brasington, R.D.3
Lenschow, D.J.4
Liang, P.5
-
15
-
-
79960434372
-
Cyclophosphamide for large vessel vasculitis: Assessment of response by PET/CT
-
Henes JC, Mueller M, Pfannenberg C, Kanz L, Koetter I. Cyclophosphamide for large vessel vasculitis: assessment of response by PET/CT. Clin Exp Rheumatol 2011;29 Suppl 64:S43-8.
-
(2011)
Clin Exp Rheumatol
, vol.29
, pp. S43-S48
-
-
Henes, J.C.1
Mueller, M.2
Pfannenberg, C.3
Kanz, L.4
Koetter, I.5
-
17
-
-
84973277735
-
The Birmingham Vasculitis Activity Score as a measure of disease activity in patients with giant cell arteritis
-
Vasculitis Clinical Research Consortium
-
Kermani TA, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA, Koening CL, et al; Vasculitis Clinical Research Consortium. The Birmingham Vasculitis Activity Score as a measure of disease activity in patients with giant cell arteritis. J Rheumatol 2016;43:1078-84.
-
(2016)
J Rheumatol
, vol.43
, pp. 1078-1084
-
-
Kermani, T.A.1
Cuthbertson, D.2
Carette, S.3
Hoffman, G.S.4
Khalidi, N.A.5
Koening, C.L.6
-
18
-
-
0022578244
-
Azathioprine in giant cell arteritis/polymyalgia rheumatica: A double-blind study
-
De Silva M, Hazleman BL. Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study. Ann Rheum Dis 1986;45:136-8.
-
(1986)
Ann Rheum Dis
, vol.45
, pp. 136-138
-
-
De Silva, M.1
Hazleman, B.L.2
-
19
-
-
84922221358
-
Adalimumab for steroid sparing in patients with giant-cell arteritis: Results of a multicentre randomised controlled trial
-
Seror R, Baron G, Hachulla E, Debandt M, Larroche C, Puechal X, et al. Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trial. Ann Rheum Dis 2014;73:2074-81.
-
(2014)
Ann Rheum Dis
, vol.73
, pp. 2074-2081
-
-
Seror, R.1
Baron, G.2
Hachulla, E.3
Debandt, M.4
Larroche, C.5
Puechal, X.6
-
20
-
-
84959451366
-
Tocilizumab for induction and maintenance of remission in giant cell arteritis: A phase 2, randomised, double-blind, placebo-controlled trial
-
Villiger PM, Adler S, Kuchen S, Wermelinger F, Dan D, Fiege V, et al. Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet 2016;387:1921-7.
-
(2016)
Lancet
, vol.387
, pp. 1921-1927
-
-
Villiger, P.M.1
Adler, S.2
Kuchen, S.3
Wermelinger, F.4
Dan, D.5
Fiege, V.6
-
21
-
-
84887785340
-
Development of a colour Doppler ultrasound scoring system in patients of Takayasu's arteritis and its correlation with clinical activity score (ITAS 2010)
-
Sinha D, Mondal S, Nag A, Ghosh A. Development of a colour Doppler ultrasound scoring system in patients of Takayasu's arteritis and its correlation with clinical activity score (ITAS 2010). Rheumatology 2013;52:2196-202.
-
(2013)
Rheumatology
, vol.52
, pp. 2196-2202
-
-
Sinha, D.1
Mondal, S.2
Nag, A.3
Ghosh, A.4
-
22
-
-
11344286518
-
Use of ultrasonography and positron emission tomography in the diagnosis and assessment of large-vessel vasculitis
-
Schmidt WA, Blockmans D. Use of ultrasonography and positron emission tomography in the diagnosis and assessment of large-vessel vasculitis. Curr Opin Rheumatol 2005;17:9-15.
-
(2005)
Curr Opin Rheumatol
, vol.17
, pp. 9-15
-
-
Schmidt, W.A.1
Blockmans, D.2
-
24
-
-
84862576812
-
Large vessel involvement in biopsy-proven giant cell arteritis: Prospective study in 40 newly diagnosed patients using CT angiography
-
Prieto-González S, Arguis P, García-Martínez A, Espígol-Frigolé G, Tavera-Bahillo I, Butjosa M, et al. Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography. Ann Rheum Dis 2012;71:1170-6.
-
(2012)
Ann Rheum Dis
, vol.71
, pp. 1170-1176
-
-
Prieto-González, S.1
Arguis, P.2
García-Martínez, A.3
Espígol-Frigolé, G.4
Tavera-Bahillo, I.5
Butjosa, M.6
-
25
-
-
84922879064
-
Effect of glucocorticoid treatment on computed tomography angiography detected large-vessel inflammation in giant-cell arteritis. A prospective, longitudinal study
-
Prieto-González S, García-Martínez A, Tavera-Bahillo I, Hernández-Rodríguez J, Gutiérrez-Chacoff J, Alba MA, et al. Effect of glucocorticoid treatment on computed tomography angiography detected large-vessel inflammation in giant-cell arteritis. A prospective, longitudinal study. Medicine 2015;94:e486.
-
(2015)
Medicine
, vol.94
, pp. e486
-
-
Prieto-González, S.1
García-Martínez, A.2
Tavera-Bahillo, I.3
Hernández-Rodríguez, J.4
Gutiérrez-Chacoff, J.5
Ma, A.6
-
26
-
-
0036275885
-
Takayasu arteritis: Utility and limitations of magnetic resonance imaging in diagnosis and treatment
-
Tso E, Flamm SD, White RD, Schvartzman PR, Mascha E, Hoffman GS. Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment. Arthritis Rheum 2002; 46:1634-42.
-
(2002)
Arthritis Rheum
, vol.46
, pp. 1634-1642
-
-
Tso, E.1
Flamm, S.D.2
White, R.D.3
Schvartzman, P.R.4
Mascha, E.5
Hoffman, G.S.6
-
27
-
-
84857835425
-
Takayasu arteritis: Intravascular contrast medium for MR angiography in the evaluation of disease activity
-
Papa M, De Cobelli F, Baldissera E, Dagna L, Schiani E, Sabbadini M, et al. Takayasu arteritis: intravascular contrast medium for MR angiography in the evaluation of disease activity. AJR Am J Roentgenol 2012;198:W279-84.
-
(2012)
AJR Am J Roentgenol
, vol.198
, pp. W279-W284
-
-
Papa, M.1
De Cobelli, F.2
Baldissera, E.3
Dagna, L.4
Schiani, E.5
Sabbadini, M.6
-
28
-
-
84857430575
-
Magnetic resonance angiography in extracranial giant cell arteritis
-
Koenigkam-Santos M, Sharma P, Kalb B, Oshinski JN, Weyand CM, Goronzy JJ, et al. Magnetic resonance angiography in extracranial giant cell arteritis. J Clin Rheumatol 2011;17:306-10.
-
(2011)
J Clin Rheumatol
, vol.17
, pp. 306-310
-
-
Koenigkam-Santos, M.1
Sharma, P.2
Kalb, B.3
Oshinski, J.N.4
Weyand, C.M.5
Goronzy, J.J.6
-
30
-
-
84929485653
-
Management of large-vessel vasculitis with FDG-PET: A systematic literature review and meta-analysis
-
Soussan M, Nicolas P, Schramm C, Katsahian S, Pop G, Fain O, et al. Management of large-vessel vasculitis with FDG-PET: a systematic literature review and meta-analysis. Medicine 2015;94:e622.
-
(2015)
Medicine
, vol.94
, pp. e622
-
-
Soussan, M.1
Nicolas, P.2
Schramm, C.3
Katsahian, S.4
Pop, G.5
Fain, O.6
-
31
-
-
33747194426
-
18F]fluorodeoxyglucose positron emission tomography is a useful tool to diagnose the early stage of Takayasu's arteritis and to evaluate the activity of the disease
-
18F]fluorodeoxyglucose positron emission tomography is a useful tool to diagnose the early stage of Takayasu's arteritis and to evaluate the activity of the disease. Mod Rheumatol 2006; 16:243-7.
-
(2006)
Mod Rheumatol
, vol.16
, pp. 243-247
-
-
Umekita, K.1
Takajo, I.2
Miyauchi, S.3
Tsurumura, K.4
Ueno, S.5
Kusumoto, N.6
-
32
-
-
84861221393
-
Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis
-
Kermani TA, Schmidt J, Crowson CS, Ytterberg SR, Hunder GG, Matteson EL, et al. Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum 2012;41:866-71.
-
(2012)
Semin Arthritis Rheum
, vol.41
, pp. 866-871
-
-
Kermani, T.A.1
Schmidt, J.2
Crowson, C.S.3
Ytterberg, S.R.4
Hunder, G.G.5
Matteson, E.L.6
-
33
-
-
0024356859
-
Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up
-
Kyle V, Cawston TE, Hazleman BL. Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up. Ann Rheum Dis 1989;48:667-71.
-
(1989)
Ann Rheum Dis
, vol.48
, pp. 667-671
-
-
Kyle, V.1
Cawston, T.E.2
Hazleman, B.L.3
-
34
-
-
77954261755
-
Takayasu arteritis-advances in diagnosis and management
-
Mason JC. Takayasu arteritis-advances in diagnosis and management. Nat Rev Rheumatol 2010;6:406-15.
-
(2010)
Nat Rev Rheumatol
, vol.6
, pp. 406-415
-
-
Mason, J.C.1
-
35
-
-
84901916399
-
Outcome of vascular interventions in Takayasu arteritis using the Takayasu Arteritis Damage Score
-
Rajappa SM. Outcome of vascular interventions in Takayasu arteritis using the Takayasu Arteritis Damage Score. Arthritis Rheum 2011;63 Suppl 10:S588.
-
(2011)
Arthritis Rheum
, vol.63
, pp. S588
-
-
Rajappa, S.M.1
-
36
-
-
85037088355
-
Cross-sectional assessment of damage in Takayasu arteritis with a validated tool
-
Omma A, Erer B, Karadag O, Yilmaz N, Alibaz-Oner F, Yildiz F, et al. Cross-sectional assessment of damage in Takayasu arteritis with a validated tool. Arthritis Rheum 2012;64 Suppl 10:S996.
-
(2012)
Arthritis Rheum
, vol.64
, pp. S996
-
-
Omma, A.1
Erer, B.2
Karadag, O.3
Yilmaz, N.4
Alibaz-Oner, F.5
Yildiz, F.6
-
37
-
-
85018333422
-
Remarkable damage along with poor quality of life in Takayasu arteritis: Cross-sectional results of a long-term followed-up multicentre cohort
-
Omma A, Erer B, Karadag O, Yilmaz N, Alibaz-Oner F, Yildiz F, et al. Remarkable damage along with poor quality of life in Takayasu arteritis: cross-sectional results of a long-term followed-up multicentre cohort. Clin Exp Rheumatol 2017;35 Suppl 103:77-82.
-
(2017)
Clin Exp Rheumatol
, vol.35
, pp. 77-82
-
-
Omma, A.1
Erer, B.2
Karadag, O.3
Yilmaz, N.4
Alibaz-Oner, F.5
Yildiz, F.6
-
38
-
-
85014388193
-
A randomized, double-blind trial of abatacept (CTLA-4Ig) for the treatment of giant cell arteritis
-
Vasculitis Clinical Research Consortium
-
Langford CA, Cuthbertson D, Ytterberg SR, Khalidi N, Monach PA, Carette S, et al; Vasculitis Clinical Research Consortium. A randomized, double-blind trial of abatacept (CTLA-4Ig) for the treatment of giant cell arteritis. Arthritis Rheumatol 2017;69:837-45.
-
(2017)
Arthritis Rheumatol
, vol.69
, pp. 837-845
-
-
Langford, C.A.1
Cuthbertson, D.2
Ytterberg, S.R.3
Khalidi, N.4
Monach, P.A.5
Carette, S.6
-
39
-
-
85014648276
-
A randomized, double-blind trial of abatacept (CTLA-4Ig) for the treatment of Takayasu arteritis
-
Vasculitis Clinical Research Consortium
-
Langford CA, Cuthbertson D, Ytterberg SR, Khalidi N, Monach PA, Carette S, et al; Vasculitis Clinical Research Consortium. A randomized, double-blind trial of abatacept (CTLA-4Ig) for the treatment of Takayasu arteritis. Arthritis Rheumatol 2017;69:846-53.
-
(2017)
Arthritis Rheumatol
, vol.69
, pp. 846-853
-
-
Langford, C.A.1
Cuthbertson, D.2
Ytterberg, S.R.3
Khalidi, N.4
Monach, P.A.5
Carette, S.6
-
40
-
-
85020866157
-
Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: Results from a randomized, double-blind, placebo-controlled, phase 3 trial in Japan
-
Nakaoka Y, Isobe M, Takei S, Tanaka Y, Ishii T, Yokota S, et al. Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomized, double-blind, placebo-controlled, phase 3 trial in Japan. Arthritis Rheumatol 2016;68 Suppl 10:976.
-
(2016)
Arthritis Rheumatol
, vol.68
, pp. 976
-
-
Nakaoka, Y.1
Isobe, M.2
Takei, S.3
Tanaka, Y.4
Ishii, T.5
Yokota, S.6
-
41
-
-
84877259423
-
Design of the tocilizumab in giant cell arteritis trial
-
Unizony SH, Dasgupta B, Fisheleva E, Rowell L, Schett G, Spiera R, et al. Design of the tocilizumab in giant cell arteritis trial. Int J Rheumatol 2013;2013:912562.
-
(2013)
Int J Rheumatol
, vol.2013
, pp. 912562
-
-
Unizony, S.H.1
Dasgupta, B.2
Fisheleva, E.3
Rowell, L.4
Schett, G.5
Spiera, R.6
-
42
-
-
0346252452
-
Laboratory investigations useful in giant cell arteritis and Takayasu's arteritis
-
Salvarani C, Cantini F, Boiardi L, Hunder GG. Laboratory investigations useful in giant cell arteritis and Takayasu's arteritis. Clin Exp Rheumatol 2003;21 Suppl 32:S23-8.
-
(2003)
Clin Exp Rheumatol
, vol.21
, pp. S23-S28
-
-
Salvarani, C.1
Cantini, F.2
Boiardi, L.3
Hunder, G.G.4
|